Approvals & regulatory · 9h ago Merck Welireg, Eisai Lenvima combo approved for kidney cancer 1 outlet Merck & Co. (MSD)
Trials & R&D · 14h ago DME red flag in Merck Brunello phase III? Surrozen finishes rich 1 outlet Merck & Co. (MSD)
Deals & business · 14h ago Merck reveals study success, and possible safety worries, for eye drug hopeful 1 outlet Merck & Co. (MSD)
Trials & R&D · 14h ago MSD’s DME drug could challenge anti-VEGF reign, late-stage study suggests 1 outlet Merck & Co. (MSD)
Approvals & regulatory · 16h ago Merck’s experimental eye drug matches Roche’s VEGF inhibitor but safety concerns emerge 1 outlet Merck & Co. (MSD) Roche
Trials & R&D · 18h ago Merck’s return to ophthalmology snags first success 1 outlet Merck & Co. (MSD)
Trials & R&D · 18h ago Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial 1 outlet Merck & Co. (MSD)
Trials & R&D · 22h ago Merck sees pivotal victory for $3B eye disease prospect 1 outlet Merck & Co. (MSD)
